Search research articles
Contact Us
Filters
Showing results (41-50 of 65) with videos related to
Page
of 7
Sort By:
British Journal of Cancer
|
March 14, 2013
Competing mortality in patients diagnosed with bladder cancer: evidence of undertreatment in the elderly and female patients
A P Noon, P C Albertsen, F Thomas, et al.
Prostate Cancer and Prostatic Diseases
|
June 29, 2011
The impact of PSA testing frequency on prostate cancer incidence and treatment in older men
Y-H Shao, P C Albertsen, W Shih, et al.
Annals of Internal Medicine
|
March 15, 1996
Estimating treatment benefits for the elderly: the effect of competing risks
H G Welch, P C Albertsen, R F Nease, et al.
JAMA
|
June 24, 2000
Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer
F J Fowler, M McNaughton Collins, P C Albertsen, et al.
Annals of Internal Medicine
|
April 1, 2000
Single-therapy androgen suppression in men with advanced prostate cancer: a systematic review and meta-analysis
J Seidenfeld, D J Samson, V Hasselblad, et al.
The Journal of Urology
|
September 1, 1984
Acquired renal cystic disease in the end stage kidney: urological implications
C B Brendler, P C Albertsen, S M Goldman, et al.
Urology
|
September 4, 1999
Expression of vascular endothelial growth factor receptors in human prostate cancer
F A Ferrer, L J Miller, R Lindquist, et al.
Journal of the National Cancer Institute
|
February 21, 1996
Follow-up prostate cancer treatments after radical prostatectomy: a population-based study
G L Lu-Yao, A L Potosky, P C Albertsen, et al.
The Journal of Urology
|
July 1, 1995
Practice trends in the diagnosis and management of prostate cancer in the United States
W F Gee, H L Holtgrewe, P C Albertsen, et al.
The Journal of Urology
|
June 1, 1997
Vascular endothelial growth factor (VEGF) expression in human prostate cancer: in situ and in vitro expression of VEGF by human prostate cancer cells
F A Ferrer, L J Miller, R I Andrawis, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 65) with videos related to
Sort By:
Page
of 7
British Journal of Cancer
|
March 14, 2013
Competing mortality in patients diagnosed with bladder cancer: evidence of undertreatment in the elderly and female patients
A P Noon, P C Albertsen, F Thomas, et al.
Prostate Cancer and Prostatic Diseases
|
June 29, 2011
The impact of PSA testing frequency on prostate cancer incidence and treatment in older men
Y-H Shao, P C Albertsen, W Shih, et al.
Annals of Internal Medicine
|
March 15, 1996
Estimating treatment benefits for the elderly: the effect of competing risks
H G Welch, P C Albertsen, R F Nease, et al.
JAMA
|
June 24, 2000
Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer
F J Fowler, M McNaughton Collins, P C Albertsen, et al.
Annals of Internal Medicine
|
April 1, 2000
Single-therapy androgen suppression in men with advanced prostate cancer: a systematic review and meta-analysis
J Seidenfeld, D J Samson, V Hasselblad, et al.
The Journal of Urology
|
September 1, 1984
Acquired renal cystic disease in the end stage kidney: urological implications
C B Brendler, P C Albertsen, S M Goldman, et al.
Urology
|
September 4, 1999
Expression of vascular endothelial growth factor receptors in human prostate cancer
F A Ferrer, L J Miller, R Lindquist, et al.
Journal of the National Cancer Institute
|
February 21, 1996
Follow-up prostate cancer treatments after radical prostatectomy: a population-based study
G L Lu-Yao, A L Potosky, P C Albertsen, et al.
The Journal of Urology
|
July 1, 1995
Practice trends in the diagnosis and management of prostate cancer in the United States
W F Gee, H L Holtgrewe, P C Albertsen, et al.
The Journal of Urology
|
June 1, 1997
Vascular endothelial growth factor (VEGF) expression in human prostate cancer: in situ and in vitro expression of VEGF by human prostate cancer cells
F A Ferrer, L J Miller, R I Andrawis, et al.
Page
of 7